| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Institute of Biochemistry, University of Lausanne, Epalinges, Switzerland; and
Department of Medicine, Evanston Hospital, Northwestern University, Evanston, Illinois 60201
FLICE-inhibitory protein, FLIP (Casper/I-FLICE/FLAME-1/CASH/CLARP/MRIT), which contains two death effector domains and an inactive caspase domain, binds to FADD and caspase-8, and thereby inhibits death receptor-mediated apoptosis. Here, we characterize the inhibitory effect of FLIP on a variety of apoptotic pathways. Human Jurkat T cells undergoing Fas ligand-mediated apoptosis in response to CD3 activation were completely resistant when transfected with FLIP. In contrast, the presence of FLIP did not affect apoptosis induced by granzyme B in combination with adenovirus or perforin. Moreover, the Fas ligand, but not the perforin/granzyme B-dependent lytic pathway of CTL, was inhibited by FLIP. Apoptosis mediated by chemotherapeutic drugs (i.e., doxorubicin, etoposide, and vincristine) and gamma irradiation was not affected by FLIP or the absence of Fas, indicating that these treatments can induce cell death in a Fas-independent and FLIP-insensitive manner.
This article has been cited by other articles:
|
|
 |
|
  J. Han, W. Hou, L. A. Goldstein, C. Lu, D. B. Stolz, X.-M. Yin, and H. Rabinowich Involvement of Protective Autophagy in TRAIL Resistance of Apoptosis-defective Tumor Cells J. Biol. Chem., July 11, 2008; 283(28): 19665 - 19677. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Elmore Apoptosis: A Review of Programmed Cell Death Toxicol Pathol, June 1, 2007; 35(4): 495 - 516. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Merino, N. Lalaoui, A. Morizot, P. Schneider, E. Solary, and O. Micheau Differential Inhibition of TRAIL-Mediated DR5-DISC Formation by Decoy Receptors 1 and 2. Mol. Cell. Biol., October 1, 2006; 26(19): 7046 - 7055. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Estella, M. D. McKenzie, T. Catterall, V. R. Sutton, P. I. Bird, J. A. Trapani, T. W. Kay, and H. E. Thomas Granzyme B-Mediated Death of Pancreatic {beta}-Cells Requires the Proapoptotic BH3-Only Molecule Bid. Diabetes, August 1, 2006; 55(8): 2212 - 2219. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Jurewicz, M. Matysiak, K. Tybor, L. Kilianek, C. S. Raine, and K. Selmaj Tumour necrosis factor-induced death of adult human oligodendrocytes is mediated by apoptosis inducing factor Brain, November 1, 2005; 128(11): 2675 - 2688. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Kriehuber, W. Bauer, A.-S. Charbonnier, D. Winter, S. Amatschek, D. Tamandl, N. Schweifer, G. Stingl, and D. Maurer Balance between NF-{kappa}B and JNK/AP-1 activity controls dendritic cell life and death Blood, July 1, 2005; 106(1): 175 - 183. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Banno, A. Gazel, and M. Blumenberg Pathway-specific Profiling Identifies the NF-{kappa}B-dependent Tumor Necrosis Factor {alpha}-regulated Genes in Epidermal Keratinocytes J. Biol. Chem., May 13, 2005; 280(19): 18973 - 18980. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Reich-Zeliger, J. Gan, E. Bachar-Lustig, and Y. Reisner Tolerance Induction by Veto CTLs in the TCR Transgenic 2C Mouse Model. II. Deletion of Effector Cells by Fas-Fas Ligand Apoptosis J. Immunol., December 1, 2004; 173(11): 6660 - 6666. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Mirandola, C. Ponti, G. Gobbi, I. Sponzilli, M. Vaccarezza, L. Cocco, G. Zauli, P. Secchiero, F. A. Manzoli, and M. Vitale Activated human NK and CD8+ T cells express both TNF-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors but are resistant to TRAIL-mediated cytotoxicity Blood, October 15, 2004; 104(8): 2418 - 2424. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Naito, R. Katayama, T. Ishioka, A. Suga, K. Takubo, M. Nanjo, C. Hashimoto, M. Taira, S. Takada, R. Takada, et al. Cellular FLIP Inhibits {beta}-Catenin Ubiquitylation and Enhances Wnt Signaling Mol. Cell. Biol., October 1, 2004; 24(19): 8418 - 8427. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. B. Werner, S. W. G. Tait, E. de Vries, E. Eldering, and J. Borst Requirement for Aspartate-cleaved Bid in Apoptosis Signaling by DNA-damaging Anti-cancer Regimens J. Biol. Chem., July 2, 2004; 279(27): 28771 - 28780. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Y. Almawi, O. K. Melemedjian, and M. M. A. Jaoude On the link between Bcl-2 family proteins and glucocorticoid-induced apoptosis J. Leukoc. Biol., July 1, 2004; 76(1): 7 - 14. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. Pastorino, N. Shulga, and J. B. Hoek TNF-{alpha}-induced cell death in ethanol-exposed cells depends on p38 MAPK signaling but is independent of Bid and caspase-8 Am J Physiol Gastrointest Liver Physiol, August 8, 2003; 285(3): G503 - G516. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Gonzalez, A. Orlofsky, and M. B. Prystowsky A1 is a growth-permissive antiapoptotic factor mediating postactivation survival in T cells Blood, April 1, 2003; 101(7): 2679 - 2685. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. E. Hirst, M. S. Buzza, C. H. Bird, H. S. Warren, P. U. Cameron, M. Zhang, P. G. Ashton-Rickardt, and P. I. Bird The Intracellular Granzyme B Inhibitor, Proteinase Inhibitor 9, Is Up-Regulated During Accessory Cell Maturation and Effector Cell Degranulation, and Its Overexpression Enhances CTL Potency J. Immunol., January 15, 2003; 170(2): 805 - 815. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Nitobe, S. Yamaguchi, M. Okuyama, N. Nozaki, M. Sata, T. Miyamoto, Y. Takeishi, I. Kubota, and H. Tomoike Reactive oxygen species regulate FLICE inhibitory protein (FLIP) and susceptibility to Fas-mediated apoptosis in cardiac myocytes Cardiovasc Res, January 1, 2003; 57(1): 119 - 128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Zheng, L.-H. Ben, J. S. Pober, and A. L. M. Bothwell Porcine Endothelial Cells, Unlike Human Endothelial Cells, Can Be Killed by Human CTL Via Fas Ligand and Cannot Be Protected by Bcl-2 J. Immunol., December 15, 2002; 169(12): 6850 - 6855. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Pinkoski, N. M. Droin, T. Lin, L. Genestier, T. A. Ferguson, and D. R. Green Nonlymphoid Fas ligand in peptide-induced peripheral lymphocyte deletion PNAS, December 10, 2002; 99(25): 16174 - 16179. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. G. Jones, A. R. Elford, M. J. Parsons, L. Wu, C. M. Krawczyk, W.-C. Yeh, R. Hakem, R. Rottapel, J. R. Woodgett, and P. S. Ohashi CD28-dependent Activation of Protein Kinase B/Akt Blocks Fas-mediated Apoptosis by Preventing Death-inducing Signaling Complex Assembly J. Exp. Med., August 5, 2002; 196(3): 335 - 348. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. A. Lens, T. Kataoka, K. A. Fortner, A. Tinel, I. Ferrero, R. H. MacDonald, M. Hahne, F. Beermann, A. Attinger, H.-A. Orbea, et al. The Caspase 8 Inhibitor c-FLIPL Modulates T-Cell Receptor-Induced Proliferation but Not Activation-Induced Cell Death of Lymphocytes Mol. Cell. Biol., August 1, 2002; 22(15): 5419 - 5433. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. H. Igney and P. H. Krammer Immune escape of tumors: apoptosis resistance and tumor counterattack J. Leukoc. Biol., June 1, 2002; 71(6): 907 - 920. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. H. Shain, T. H. Landowski, and W. S. Dalton Adhesion-Mediated Intracellular Redistribution of c-Fas-Associated Death Domain-Like IL-1-Converting Enzyme-Like Inhibitory Protein-Long Confers Resistance to CD95-Induced Apoptosis in Hematopoietic Cancer Cell Lines J. Immunol., March 1, 2002; 168(5): 2544 - 2553. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Krueger, S. Baumann, P. H. Krammer, and S. Kirchhoff FLICE-Inhibitory Proteins: Regulators of Death Receptor-Mediated Apoptosis Mol. Cell. Biol., December 15, 2001; 21(24): 8247 - 8254. [Full Text] [PDF]
|
|
|
|
|
|
I. Herr and K.-M. Debatin Cellular stress response and apoptosis in cancer therapy Blood, November 1, 2001; 98(9): 2603 - 2614. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Taylor, P. M. Chaudhary, J. Klem, V. Kumar, J. D. Schatzle, and M. Bennett Inhibition of the Death Receptor Pathway by cFLIP Confers Partial Engraftment of MHC Class I-Deficient Stem Cells and Reduces Tumor Clearance in Perforin-Deficient Mice J. Immunol., October 15, 2001; 167(8): 4230 - 4237. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. R. Jerome, Z. Chen, R. Lang, M. R. Torres, J. Hofmeister, S. Smith, R. Fox, C. J. Froelich, and L. Corey HSV and Glycoprotein J Inhibit Caspase Activation and Apoptosis Induced by Granzyme B or Fas J. Immunol., October 1, 2001; 167(7): 3928 - 3935. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Medema, J. de Jong, L. T. C. Peltenburg, E. M. E. Verdegaal, A. Gorter, S. A. Bres, K. L. M. C. Franken, M. Hahne, J. P. Albar, C. J. M. Melief, et al. Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors PNAS, September 13, 2001; (2001) 201398198. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Medema, D. H. Schuurhuis, D. Rea, J. van Tongeren, J. de Jong, S. A. Bres, S. Laban, R. E.M. Toes, M. Toebes, T. N.M. Schumacher, et al. Expression of the Serpin Serine Protease Inhibitor 6 Protects Dendritic Cells from Cytotoxic T Lymphocyte-induced Apoptosis: Differential Modulation by T Helper Type 1 and Type 2 Cells J. Exp. Med., September 4, 2001; 194(5): 657 - 668. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Screpanti, R. P. A. Wallin, H.-G. Ljunggren, and A. Grandien A Central Role for Death Receptor-Mediated Apoptosis in the Rejection of Tumors by NK Cells J. Immunol., August 15, 2001; 167(4): 2068 - 2073. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Laurent and J.-P. Jaffrezou Signaling pathways activated by daunorubicin Blood, August 15, 2001; 98(4): 913 - 924. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-H. Lai, L.-J. Ho, K.-C. Lu, D.-M. Chang, M.-F. Shaio, and S.-H. Han Western and Chinese Antirheumatic Drug-Induced T Cell Apoptotic DNA Damage Uses Different Caspase Cascades and Is Independent of Fas/Fas Ligand Interaction J. Immunol., June 1, 2001; 166(11): 6914 - 6924. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Droin, F. Bichat, C. Rebe, A. Wotawa, O. Sordet, A. Hammann, R. Bertrand, and E. Solary Involvement of caspase-2 long isoform in Fas-mediated cell death of human leukemic cells Blood, March 15, 2001; 97(6): 1835 - 1844. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Salvucci, M. Carsana, I. Bersani, G. Tragni, and A. Anichini Antiapoptotic Role of Endogenous Nitric Oxide in Human Melanoma Cells Cancer Res., January 1, 2001; 61(1): 318 - 326. [Abstract] [Full Text]
|
|
|
|
|
|
H. Yoshikawa, Y. Nakajima, and K. Tasaka Enhanced Expression of Fas-Associated Death Domain-Like IL-1-Converting Enzyme (FLICE)-Inhibitory Protein Induces Resistance to Fas-Mediated Apoptosis in Activated Mast Cells J. Immunol., December 1, 2000; 165(11): 6262 - 6269. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Barry, J. A. Heibein, M. J. Pinkoski, S.-F. Lee, R. W. Moyer, D. R. Green, and R. C. Bleackley Granzyme B Short-Circuits the Need for Caspase 8 Activity during Granule-Mediated Cytotoxic T-Lymphocyte Killing by Directly Cleaving Bid Mol. Cell. Biol., June 1, 2000; 20(11): 3781 - 3794. [Abstract] [Full Text]
|
|
|
|
|
|
K. Nagaraju, L. Casciola-Rosen, A. Rosen, C. Thompson, L. Loeffler, T. Parker, C. Danning, P. J. Rochon, J. Gillespie, and P. Plotz The Inhibition of Apoptosis in Myositis and in Normal Muscle Cells J. Immunol., May 15, 2000; 164(10): 5459 - 5465. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. S. Bergmann-Leitner and S. I. Abrams Differential Role of Fas/Fas Ligand Interactions in Cytolysis of Primary and Metastatic Colon Carcinoma Cell Lines by Human Antigen-Specific CD8+ CTL J. Immunol., May 1, 2000; 164(9): 4941 - 4954. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Y. Hsu and A. J. W. Hsueh Tissue-Specific Bcl-2 Protein Partners in Apoptosis: An Ovarian Paradigm Physiol Rev, April 1, 2000; 80(2): 593 - 614. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Kumar, T. L. Whiteside, and U. Kasid Identification of a Novel Tumor Necrosis Factor-alpha -inducible Gene, SCC-S2, Containing the Consensus Sequence of a Death Effector Domain of Fas-associated Death Domain-like Interleukin- 1beta -converting Enzyme-inhibitory Protein J. Biol. Chem., January 28, 2000; 275(4): 2973 - 2978. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Newton and A. Strasser Ionizing Radiation and Chemotherapeutic Drugs Induce Apoptosis in Lymphocytes in the Absence of Fas or FADD/MORT1 Signaling: Implications for Cancer Therapy J. Exp. Med., January 3, 2000; 191(1): 195 - 200. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. G. Ferreira, C. Tolis, S. W. Span, G. J. Peters, T. van Lopik, A. J. Kummer, H. M. Pinedo, and G. Giaccone Drug-induced Apoptosis in Lung Cancer Cells Is Not Mediated by the Fas/FasL (CD95/APO1) Signaling Pathway Clin. Cancer Res., January 1, 2000; 6(1): 203 - 212. [Abstract] [Full Text]
|
|
|
|
 |
|
 K. R. Jerome, R. Fox, Z. Chen, A. E. Sears, H.-y. Lee, and L. Corey Herpes Simplex Virus Inhibits Apoptosis through the Action of Two Genes, Us5 and Us3 J. Virol., November 1, 1999; 73(11): 8950 - 8957. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. E. French and J. Tschopp Inhibition of Death Receptor Signaling by FLICE-inhibitory Protein as a Mechanism for Immune Escape of Tumors J. Exp. Med., October 4, 1999; 190(7): 891 - 894. [Full Text] [PDF]
|
|
|
|
|
|
J. P. Medema, J. de Jong, T. van Hall, C. J.M. Melief, and R. Offringa Immune Escape of Tumors In Vivo by Expression of Cellular FLICE-inhibitory Protein J. Exp. Med., October 4, 1999; 190(7): 1033 - 1038. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Scaffidi, I. Schmitz, J. Zha, S. J. Korsmeyer, P. H. Krammer, and M. E. Peter Differential Modulation of Apoptosis Sensitivity in CD95 Type I and Type II Cells J. Biol. Chem., August 6, 1999; 274(32): 22532 - 22538. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Panka, T. Mano, T. Suhara, K. Walsh, and J. W. Mier Phosphatidylinositol 3-Kinase/Akt Activity Regulates c-FLIP Expression in Tumor Cells J. Biol. Chem., March 2, 2001; 276(10): 6893 - 6896. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Nesterov, X. Lu, M. Johnson, G. J. Miller, Y. Ivashchenko, and A. S. Kraft Elevated Akt Activity Protects the Prostate Cancer Cell Line LNCaP from TRAIL-induced Apoptosis J. Biol. Chem., March 30, 2001; 276(14): 10767 - 10774. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Medema, J. de Jong, L. T. C. Peltenburg, E. M. E. Verdegaal, A. Gorter, S. A. Bres, K. L. M. C. Franken, M. Hahne, J. P. Albar, C. J. M. Melief, et al. Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors PNAS, September 25, 2001; 98(20): 11515 - 11520. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
